You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Glenmark Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has one hundred and sixty-six approved drugs.

There are eight tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms
US Patents:0
Tradenames:134
Ingredients:126
NDAs:166

Drugs and US Patents for Glenmark Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd LEVONORGESTREL levonorgestrel TABLET;ORAL 207044-001 Mar 25, 2016 OTC No No ⤷  Subscribe ⤷  Subscribe
Glenmark Pharms Ltd THEOPHYLLINE theophylline TABLET, EXTENDED RELEASE;ORAL 212184-002 Jun 3, 2021 AB RX No No ⤷  Subscribe ⤷  Subscribe
Glenmark Pharms Ltd ZOLMITRIPTAN zolmitriptan TABLET;ORAL 201779-001 May 14, 2013 AB RX No No ⤷  Subscribe ⤷  Subscribe
Glenmark Pharms Ltd COLESEVELAM HYDROCHLORIDE colesevelam hydrochloride TABLET;ORAL 203480-001 May 18, 2018 AB RX No No ⤷  Subscribe ⤷  Subscribe
Glenmark Pharms Ltd BRIELLYN ethinyl estradiol; norethindrone TABLET;ORAL-28 090538-001 Mar 22, 2011 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for GLENMARK PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.